Discovering & Developing Best-In-Class PROTACs, Molecular Glues & Emerging Proximity Modalities with Improved Safety, Pharmacology & Translational Potential in Oncology & Beyond
2026 has reshaped the induced proximity landscape, with approvals for a PROTAC, molecular glue and CELMoD degrader demonstrating that targeted protein degradation can successfully translate into transformative medicines. Building on this momentum, European biopharma is investing heavily in the next generation of induced proximity therapies, advancing novel biology, new mechanisms of action and increasingly diverse therapeutic applications.
Returning to London at this inflection point for the field, the 7th TPD & Induced Proximity Summit Europe will unite the scientists driving the future of induced proximity. Spanning PROTACs, molecular glues, DACs and emerging non-degrading modalities, the meeting will spotlight cutting-edge discovery technologies, preclinical advances and translational strategies aimed at broadening the impact of induced proximity across oncology, immunology, CNS and beyond.
Really good science, nice presentations, and the opportunity to connect and re-connect with other scientists working in the TPD field.
Chief Technology Officer, Sibylla Biotech
I enjoyed learning about the latest advances in targeted protein degradation from both the small- and large-molecule perspectives. What stood out was how many of the approaches discussed are moving toward translational and clinical applications.
Executive Director, Pinetree Therapeutics
Hanson Wade Summits have been vital in helping me communicate with experts in TPD drug discovery and development, and it has been an absolute pleasure to participate in these meetings.
Executive Director, Autotac Bio
Explore the Full Event Guide
- Discovery & Preclinical Breakthroughs Across Glues, Heterobifunctionals, Novel Degraders & Non-Degrading Mechanisms
- Deep-Dive, Discussion-Led Workshops on Expanding the Ligase Toolbox & Predicting Degradation
- Data-Led Presentations from 6 Brand New Academic Innovators
- 5 Brand New Biotech Companies Taking to the Stage for the First Time
Expert Speakers Include:
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Discover three days of content spanning PROTACs, glues, antibody-based degradation and non-degrading mechanisms.
Partner With Us
Elevate your brand and showcase your solutions to a world-class audience of induced proximity drug developers.
Join Biopharma Experts
Uniting large pharma experts, C-Level biotech leaders and KOLs, this forum is designed to foster vital industry connections.